These biotech ETFs are flourishing this year and some could be future winners with or without Covid-19.
By Todd Shriber
1. SPDR S&P Biotech ETF (NYSEARCA:XBI)
2. ARK Genomic Revolution ETF (CBOE:ARKG)
3. ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)
4. Principal Healthcare Innovators Index ETF (NASDAQ:BTEC)
5. First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT)
6. Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR)
7. ETFMG Treatments, Testing and Advancements ETF (NYSEARCA:GERM)
Source: InvestorPlace
https://investorplace.com/2020/08/7-bio ... h=nonbuyer